| Meta-analysis of adverse cardiovascular events associated with echocardiographic contrast agents. | |
| | |
MedLine Citation:
|
PMID: 20723656 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In October 2007, the Federal Drug Agency issued a black box warning for contrast agents used in patients undergoing echocardiography and restricted their use in patients with acute coronary syndrome, a decompensated heart, and respiratory failure. We performed a systemic review and meta-analysis to study the adverse effects of contrast agents used with respect to myocardial infarction and all-cause mortality. MEDLINE, EMBASE, BIOSIS, and Cochrane databases from inception to October 2009 were searched for studies that reported myocardial infarction and all-cause mortality after the use of contrast agents for echocardiography. A total of 8 studies were included in the present meta-analysis. A random-effect model was used, and between-studies heterogeneity was estimated with I(2). A total of 8 studies reported death as an outcome and only 4 reported myocardial infarction. The incidence of death in the contrast group was 0.34% (726 of 211,162 patients) compared to 0.9% (45,970 of 5,078,666 patients) in the noncontrast group. The pooled odds ratio was 0.57 (95% confidence interval 0.32 to 1.01, p = 0.05). The reported incidence of myocardial infarction in the contrast group was 0.15% (86 of 57,264 patients) compared to 0.2% (92 of 44,503 patients) in the noncontrast group. The pooled odds ratio was 0.85 (95% confidence interval 0.35 to 2.05, p = 0.72). Significant heterogeneity was seen among the studies. In conclusion, the cumulative evidence has suggested that the use of contrast agents for echocardiography is safe and not associated with a greater incidence of myocardial infarction or and mortality. |
| | |
Authors:
|
Owais A Khawaja; Kamran A Shaikh; Mouaz H Al-Mallah |
Related Documents
:
|
17670756 - Field triage to primary angioplasty combined with emergency department bypass reduces t... 17697156 - Long-term use of swedish moist snuff and the risk of myocardial infarction amongst men. 11466096 - Right heart catheterization and cardiac complications in patients undergoing noncardiac... 17270296 - Effects of perindopril on long-term clinical outcome of patients with coronary artery d... 8333796 - Implications of triiodothyronine administration before cardiac and noncardiac operations. 10599956 - Transmyocardial laser revascularization with the holmium:yag laser does not improve myo... |
Publication Detail:
|
Type: Journal Article; Meta-Analysis; Review Date: 2010-07-23 |
Journal Detail:
|
Title: The American journal of cardiology Volume: 106 ISSN: 1879-1913 ISO Abbreviation: Am. J. Cardiol. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-08-20 Completed Date: 2010-09-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 742-7 Citation Subset: AIM; IM |
Copyright Information:
|
2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Internal Medicine, Providence Hospital, Southfield, Michigan, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Contrast Media
/
adverse effects* Echocardiography / adverse effects*, mortality Humans Myocardial Infarction / chemically induced*, mortality |
| Chemical | |
Reg. No./Substance:
|
0/Contrast Media |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart...
Next Document: Novel Hypertrophic Cardiomyopathy Phenotype: Segmental Hypertrophy Isolated to the Posterobasal Left...